Utah Medical Products Q3 net income rises 6% to $2.79 million as revenue falls 12%
UTMD•Utah Medical Products reported third-quarter 2026 net income of $2.79 million, up 6% year over year, while revenue fell 12% to $8.62 million. Management projects full-year revenue to decline close to 7%.
1. Quarterly results
Third-quarter diluted earnings rose 7% year over year to $0.876 per share, while revenue fell 12% to $8.62 million, largely due to lost business from two previously major customers. For January through September, diluted earnings dropped 5% to $2.537 per share and revenue declined 12% to $25.87 million. Femcare acquired UK-based Orion Medical Supplies at the end of August for $5.01 million, including acquisition costs; Orion contributed $619,000 in third-quarter revenue.
